Share on LinkedInShare on LinkedIn

ARTICLE · 27 JULY 2026

DEA Inspections And Information Requests: What You Need To Know

The Drug Enforcement Agency has begun conducting inspections of medical marijuana facilities following the rescheduling order, with regional offices reaching out to applicants and requesting detailed documentation on corporate structure, security protocols, and compliance procedures. While the process has unfolded smoothly thus far, operators must understand how federal DEA regulations layer onto existing state requirements to ensure swift processing of registration applications.

United StatesGovernment, Public Sector

While the medical marijuana rescheduling order made clear that the Drug Enforcement Agency (“DEA”) would prioritize the review of medical marijuana applications submitted during the first sixty (60) days of the application window, we are watching now the details and process of that review come into picture.

DEA field offices have kicked off inspections, not just in medical-only states, but also now in states with both medical and adult-use licensed businesses. While this process, at times, can differ depending on the individual field offices involved, many common themes have emerged by virtue of the questions asked, information requested, and physical inspections of facilities to date. Moreover, this process also reveals the initial scope of federal oversight as it relates to existing DEA regulatory requirements, and how those requirements differ, complement, and/or layer on top of the state-based controls forming the core of this regulated industry.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from